FBRX

Conviction 86HealthcareScan · Mon, Aug 10, 2026

FBRX$76.83+0.05%

ResistanceSupportVol 14

Vol MA14 2.94M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Forte Biosciences, Inc.PHARMACEUTICAL PREPARATIONSwww.fortebiorx.com ↗

Price76.83

Change+0.05%

Gap+0.00%

Rel volume1.30×

Avg volume2.27M

Avg $ vol165.74M

SMA 2064.70

SMA 5038.47

SMA 20028.34

Price vs 50+99.73%

Price vs 200+171.13%

MA stackbullish

50/200 cross—

Supertrendup · 69.10

RSI (14)85

MACD hist-0.27

MACD crossbear · 0d

Stoch %K / %D99 / 99

ADX (14)76

+DI / −DI49 / 2

RSI divergence—

MACD divergence—

ATR %+3.83%

ADR %5.26%

52w high76.98

52w low10.18

From 52w high-0.19%

Above 52w low+655.09%

New 52w highYes

SqueezeOff

Bollinger width85.03%

%B0.72

Donchian pos98.99%

Donchian high77.20

Donchian low40.73

AVWAP (52w high)76.76

vs AVWAP high+0.09%

AVWAP (52w low)46.89

vs AVWAP low+63.87%

OBV trendUp

Chaikin MF (20)0.06

Today vs 20d1.30×

Avg vol (14d)2.94M

Avg vol (20d)2.27M

Avg $ vol (20d)165.74M

Market cap1.07B

RS 3m (vs SPY)+187.73%

RS 6m (vs SPY)+152.43%

RS line new highNo

Trend template8/8

Technical rank96.1

1 week+0.29%

1 month+74.93%

3 months+219.86%

6 months+178.47%

1 year+645.92%

YTD+225.41%

P/E-15.38

P/B25.34

P/S—

P/FCF-20.92

EPS-4.71

Div yield—

ROE-164.79%

ROA-103.20%

Debt/Eq0.52

Current2.75

EV/EBITDA—

Gross margin—

Net margin—

Rev growth-99.80%

EPS growth-95.54%

Price target74.00

Target upside-3.68%

Analyst ratingHold

Institutional80.30%

Ent. value1.03B

Revenue9K

Net income-22.14M

Gross profit—

Free cash flow-51M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out20.48M

Employees22

ListedTue, Jun 16, 2020

Free float7.51M

Float %60.0%

Short interest2.06M

Days to cover1.7d

Short volume6.3%

Squeeze score53 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.24

Last surprise—

Setup gradeA

Conviction86 / 100

Pattern quality—

Tech rank96.1 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance61.28

Support16.95

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in FBRX

All disclosures →

No recent disclosed trades by Congress in FBRX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in FBRX · 6 buys

Insider	Side	Shares	Value	Traded	Filed
Kornfeld Steven Director · Restricted Stock Units · 2026-05-29	Grant	18.35K	$0	2026-05-29	2026-06-02
Kapoor Shivpreet Singh Director · Restricted Stock Units · 2026-05-29	Grant	18.35K	$0	2026-05-29	2026-06-02
GRYSKA DAVID W Director · Restricted Stock Units · 2026-05-29	Grant	18.35K	$0	2026-05-29	2026-06-02
Doberstein Stephen K Director · Restricted Stock Units · 2026-05-29	Grant	18.35K	$0	2026-05-29	2026-06-02
Brun Scott C. Director · Restricted Stock Units · 2026-05-29	Grant	18.35K	$0	2026-05-29	2026-06-02
VINCENT RICHARD G Director · Restricted Stock Units · 2026-05-29	Grant	18.35K	$0	2026-05-29	2026-06-02

SEC filings

EDGAR filings in FBRX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.